Clinical Trial Update: Pharmacokinetics of JULUCA in Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of JULUCA (dolutegravir and rilpivirine) in people with HIV/AIDS and end-stage renal disease on hemodialysis. The results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• HIV Aids

Drugs mentioned

• Juluca (dolutegravir + rilpivirine)

Snippet

Sponsor: Indiana University | Conditions: HIV/AIDS, ESRD | Phase 4 | Status: COMPLETED | Results posted: 2024-05-21